Is There A Role for Limited Parotid Resections for Primary Malignant Parotid Tumors?
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Spiro, I.J.; Wang, C.C.; Montgomery, W.W. Carcinoma of the parotid gland. Analysis of treatment results and patterns of failure after combined surgery and radiation therapy. Cancer 1993, 71, 2699–2705. [Google Scholar] [CrossRef]
- Stennert, E.; Kisner, D.; Jungehuelsing, M.; Guntinas-Lichius, O.; Schröder, U.; Eckel, H.E.; Klussmann, J.P. High incidence of lymph node metastasis in major salivary gland cancer. Arch. Otolaryngol. Head Neck Surg. 2003, 129, 720–723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boahene, D.K.; Olsen, K.D.; Lewis, J.E.; Pinheiro, A.D.; Pankratz, V.S.; Bagniewski, S.M. Mucoepidermoid carcinoma of the parotid gland: The Mayo clinic experience. Arch. Otolaryngol. Head Neck Surg. 2004, 130, 849–856. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vander Poorten, V.L.; Balm, A.J.; Hilgers, F.J.; Tan, I.B.; Loftus-Coll, B.M.; Keus, R.B.; van Leeuwen, F.E.; Hart, A.A. The development of a prognostic score for patients with parotid carcinoma. Cancer 1999, 85, 2057–2067. [Google Scholar] [CrossRef]
- Cracchiolo, J.R.; Shaha, A.R. Parotidectomy for parotid cancer. Otolaryngol. Clin. N. Am. 2016, 49, 415–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lewis, A.G.; Tong, T.; Maghami, E. Diagnosis and management of malignant salivary gland tumors of the parotid gland. Otolaryngol. Clin. N. Am. 2016, 49, 343–380. [Google Scholar] [CrossRef]
- Lombardi, D.; Mcgurk, M.; vander Poorten, V.; Guzzo, M.; Accorona, R.; Rampinelli, V.; Nicolai, P. Surgical treatment of salivary malignant tumors. Oral Oncol. 2017, 65, 102–113. [Google Scholar] [CrossRef]
- Olsen, K.D.; Quer, M.; de Bree, R.; van der Poorten, V.; Rinaldo, A.; Ferlito, A. Deep lobe parotidectomy-why, when, and how? Eur. Arch. Otorhinolaryngol. 2017, 274, 4073–4078. [Google Scholar] [CrossRef] [Green Version]
- Thielker, J.; Grosheva, M.; Ihrler, S.; Wittig, A.; Guntinas-Lichius, O. Contemporary Management of Benign and Malignant Parotid Tumors. Front. Surg. 2018, 5, 39. [Google Scholar] [CrossRef] [Green Version]
- Carlson, E.R.; Schlieve, T. Salivary Gland Malignancies. Oral Maxillofac. Surg. Clin. N. Am. 2019, 31, 125–144. [Google Scholar] [CrossRef]
- Lim, Y.C.; Lee, S.Y.; Kim, K.; Lee, J.S.; Koo, B.S.; Shin, H.A.; Choi, E.C. Conservative parotidectomy for the treatment of parotid cancer. Oral Oncol. 2005, 41, 1021–1027. [Google Scholar] [CrossRef] [PubMed]
- Mantsopoulos, K.; Koch, M.; Iro, H. Extracapsular dissection as sole therapy for small low-grade malignant tumors of the parotid gland. Laryngoscope 2017, 127, 1804–1807. [Google Scholar] [CrossRef] [PubMed]
- Renehan, A.G.; Gleave, E.N.; Slevin, N.J.; McGurk, M. Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br. J. Cancer 1999, 80, 1296–1300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Witt, R.L. Facial nerve function after partial superficial parotidectomy: An 11-year review (1987–1997). Otolaryngol. Head Neck Surg. 1999, 121, 210–213. [Google Scholar] [CrossRef]
- McGurk, M.; Thomas, B.L.; Renehan, A.G. Extracapsular dissection for clinically benign parotid lumps: Reduced morbidity without oncological compromise. Br. J. Cancer 2003, 89, 1610–1613. [Google Scholar] [CrossRef]
- Cockerill, C.C.; Gross, B.D.; Contag, S.; Rein, S.; Moore, E.J.; Olsen, K.D.; Orvidas, L.J. Pediatric malignant salivary gland tumors: 60 year follow up. Int. J. Pediatr. Otorhinolaryngol. 2016, 88, 1–6. [Google Scholar] [CrossRef]
- Stodulski, D.; Mikaszewski, B.; Majewska, H.; Wiśniewski, P.; Stankiewicz, C. Close surgical margin after conservative parotidectomy in early stage low-/intermediate grade parotid carcinoma: Outcome of watch and wait policy. Oral Oncol. 2017, 68, 1–4. [Google Scholar] [CrossRef]
- Mantsopoulos, K.; Mueller, S.; Goncalves, M.; Koch, M.; Iro, H. Completion surgery after extracapsular dissection of low-grade parotid gland malignant tumors. Head Neck 2019, 41, 3383–3388. [Google Scholar] [CrossRef]
- Mantsopoulos, K.; Velegrakis, S.; Iro, H. Unexpected detection of parotid gland malignancy during primary extracapsular dissection. Otolaryngol. Head Neck Surg. 2015, 152, 1042–1047. [Google Scholar] [CrossRef] [Green Version]
- El-Naggar, A.K.; Chan, J.K.C.; Grandis, J.R.; Takata, T.; Slootweg, P.J. (Eds.) WHO Classification of Head and Neck Tumors, 4th ed.; International Agency for Research on Cancer: Lyon, France, 2017. [Google Scholar]
- Mamelle, G. Total versus partial parotidectomy. In Controversies in the Management of Salivary Glands Disease; McGurk, M., Combes, J., Eds.; Oxford University Press: Oxford, UK, 2013; pp. 194–202. [Google Scholar]
- Theriault, C.; Fitzpatrick, P.J. Malignant Parotid Tumors Prognostic Factors and Optimum Treatment. Am. J. Clin. Oncol. 1986, 9, 510–516. [Google Scholar] [CrossRef]
- Vartanian, J.G.; Gonçalves Filho, J.; Kowalski, L.P.; Shah, J.P.; Suárez, C.; Rinaldo, A.; De Bree, R.; Rodrigo, J.P.; Hamoir, M.; Takes, R.P.; et al. An evidence-based analysis of the management of N0 neck in patients with cancer of the parotid gland. Expert Rev. Anticancer Ther. 2019, 19, 899–908. [Google Scholar] [CrossRef]
- Terhaard, C.H.; Lubsen, H.; Van der Tweel, I.; Hilgers, F.J.; Eijkenboom, W.M.; Marres, H.A.; Tjho-Heslinga, R.E.; de Jong, J.M.; Roodenburg, J.L.; Dutch Head and Neck Oncology Cooperative Group. Salivary gland carcinoma: Independent prognostic factors for locoregional control, distant metastases, and overall survival: Results of the Dutch head and neck oncology cooperative group. Head Neck 2004, 26, 681–692. [Google Scholar] [CrossRef]
- McKean, M.E.; Lee, K.; McGregor, I.A. The distribution of lymph nodes in and around the parotid gland: An anatomical study. Br. J. Plast. Surg. 1985, 38, 1–5. [Google Scholar] [CrossRef]
- Pisani, P.; Ramponi, A.; Pia, F. The deep parotid lymph nodes: An anatomical and oncological study. J. Laryngol. Otol. 1996, 110, 148–150. [Google Scholar] [CrossRef] [PubMed]
- Garatea-Crelgo, J.; Gay-Escoda, C.; Bermejo, B.; Buenechea-Imaz, R. Morphological study of the parotid lymph nodes. J. Craniomaxillofac. Surg. 1993, 21, 207–209. [Google Scholar] [CrossRef]
- Klussmann, J.P.; Ponert, T.; Mueller, R.P.; Dienes, H.P.; Guntinas-Lichius, O. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur. J. Surg. Oncol. 2008, 34, 932–937. [Google Scholar] [CrossRef] [PubMed]
- Olsen, K.D.; Moore, E.J. Deep lobe parotidectomy: Clinical rationale in the management of primary and metastatic cancer. Eur. Arch. Otorhinolaryngol. 2014, 271, 1181–1185. [Google Scholar] [CrossRef]
- Nisa, L.; Salmina, C.; Dettmer, M.S.; Arnold, A.; Aebersold, D.M.; Borner, U.; Giger, R. Implications of intraglandular lymph node metastases in primary carcinomas of the parotid gland. Laryngoscope 2015, 125, 2099–2106. [Google Scholar] [CrossRef]
- Mantsopoulos, K.; Koch, M.; Klintworth, N.; Zenk, J.; Iro, H. Evolution and changing trends in surgery for benign parotid tumors. Laryngoscope 2015, 125, 122–127. [Google Scholar] [CrossRef]
- Quer, M.; Guntinas-Lichius, O.; Marchal, F.; Vander Poorten, V.; Chevalier, D.; León, X.; Eisele, D.; Dulguerov, P. Classification of parotidectomies: A proposal of the European Salivary Gland Society. Eur. Arch. Otorhinolaryngol. 2016, 273, 3307–3312. [Google Scholar] [CrossRef]
- Witt, R.L. Extracapsular dissection with facial nerve dissection for benign parotid tumors. Otolaryngol. Head Neck Surg. 2016, 154, 572–574. [Google Scholar] [CrossRef]
- Quer, M.; Vander Poorten, V.; Takes, R.P.; Silver, C.E.; Boedeker, C.R.; de Bree, R.; Rinaldo, A.; Sanabria, A.; Shaha, A.R.; Pujol, A.; et al. Surgical options in benign parotid tumors: A proposal for classification. Eur. Arch. Otorhinolaryngol. 2017, 274, 3825–3836. [Google Scholar] [CrossRef] [PubMed]
- Del Signore, A.G.; Megwalu, U.C. The rising incidence of major salivary gland cancer in the United States. ENT Ear Nose Throat J. 2017, 96, E13–E16. [Google Scholar] [CrossRef] [PubMed]
- Lin, A.C.; Bhattacharyya, N. The utility of fine needle aspiration in parotid malignancy. Otolaryngol. Head Neck Surg. 2007, 136, 793–798. [Google Scholar] [CrossRef] [PubMed]
- Lundberg, M.; Munsterhjelm, B.; Mäkitie, A.; Leivo, I. Immunohistochemical Staining of Histological Fragments Derived from Salivary Gland Tumor Fine-Needle Biopsy Aspirates. Acta Cytol. 2017, 61, 17–20. [Google Scholar] [CrossRef]
- Zbären, P.; Triantafyllou, A.; Devaney, K.O.; Vander Poorten, V.; Hellquist, H.; Rinaldo, A.; Ferlito, A. Preoperative diagnostic of parotid gland neoplasms: Fine-needle aspiration cytology or core needle biopsy? Eur. Arch. Otorhinolaryngol. 2018, 275, 2609–2613. [Google Scholar] [CrossRef] [Green Version]
- Witt, B.L.; Schmidt, R.L. Ultrasound-guided core needle biopsy of salivary gland lesions: A systematic review and meta-analysis. Laryngoscope 2014, 124, 695–700. [Google Scholar] [CrossRef]
Year | Authors | Number of Cases. Complementary Treatment | Histolo-Gical Type | Local Control (LC) and Survival |
---|---|---|---|---|
1999 | Renehan et al. [13] | 24 extracapsular dissection (ECD) (13 post-op radiotherapy) | No specific information | 79% LC (5 recurrences). 68% 10 years overall survival. |
1999 | Witt [14] | 1 PLL (low-grade, < 3 cm) (No information on complementary treatment) | 1 MEPCA | 100% LC No data on survival |
2003 | McGurk et al. [15] | 12 ECD in selected cases (discrete, mobile, and less than 4 cm in diameter) (7 post-op radiotherapy) | 1 ACC 1 AdCC 7 MEPCA 3 others (no specified) | 91.7% LC (1 recurrence) 100% The 10-year cancer-specific survival |
2005 | Lim et al. [11] | 43 “conservative parotidectomy” (less than superficial) (10 post-op radiotherapy) | Low-grade: 11 ACC 9 MEPCA 6 BCC 1 AdCC High-grade: 5 MEPCA 4 AdCC 3 CEPA 2 ADC 2 SCC | 90.5% LC (4 recurrences) 88% 5 years overall survival |
2016 | Cockerill et al. [16] | 11 Enucleation (No information on complementary treatment) | No specific information | 36% LC (7 recurrences) |
2017 | Stodulski et al. [17] | 2 PLL (II) low-intermediate grade, (one T1 and one T2) with close margins (No post-op radiotherapy) | 1 AdCC 1MEPCA | 100% LC 100% cancer-specific survival |
2019 | Mantsopoulos et al. [12,18,19] | 14 ECD low grade (13 T1 and one T2). Free margins (No post-op radiotherapy) | 4 ACC 1 BCC 2 CEPA 7 MEPCA | 100% LC 100% cancer-specific survival |
TOTAL CASES | PLL | 46 cases (10 post-op radiotherapy) | 91% (4 recurrences) | |
TOTAL CASES | ECD | 50 cases (20 post-op radiotherapy) | 88% LC (6 recurrences) | |
Enucleation | 11 cases (no information on radio) | 36% LC (7 recurrences) |
Table | Stage | Extension of Parotidectomy | |
---|---|---|---|
Suspected malign tumour | Stage I-II (T1-2N0M0) | Low grade (and superficial) | Lateral parotidectomy (Less than lateral parotidectomy in very selected cases can be considered, but more prospective data are needed to generalise this indication) |
High grade or intermediate grade or any grade in deep lobe | Total parotidectomy | ||
Stage III–IV | Total parotidectomy | ||
Presumably, benign tumour but definitive histology reveals malignancy * | Stage I-II (pT1-2 N0M0) | Free margins, superficial, low grade | Close follow-up |
Margins affected, more than low grade | Complete a total parotidectomy | ||
Stage III–IV | Complete a total parotidectomy ** |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Quer, M.; Olsen, K.D.; Silver, C.E.; Hamoir, M.; Mäkitie, A.A.; Rodrigo, J.P.; Vander Poorten, V.; Takes, R.P.; Hellquist, H.; García Lorenzo, J.; et al. Is There A Role for Limited Parotid Resections for Primary Malignant Parotid Tumors? Surgeries 2020, 1, 2-9. https://doi.org/10.3390/surgeries1010002
Quer M, Olsen KD, Silver CE, Hamoir M, Mäkitie AA, Rodrigo JP, Vander Poorten V, Takes RP, Hellquist H, García Lorenzo J, et al. Is There A Role for Limited Parotid Resections for Primary Malignant Parotid Tumors? Surgeries. 2020; 1(1):2-9. https://doi.org/10.3390/surgeries1010002
Chicago/Turabian StyleQuer, Miquel, Kerry D. Olsen, Carl E. Silver, Marc Hamoir, Antti A. Mäkitie, Juan P. Rodrigo, Vincent Vander Poorten, Robert P. Takes, Henrik Hellquist, Jacinto García Lorenzo, and et al. 2020. "Is There A Role for Limited Parotid Resections for Primary Malignant Parotid Tumors?" Surgeries 1, no. 1: 2-9. https://doi.org/10.3390/surgeries1010002